Lymphoma Cancer | Tumor

Poteligeo May Result in Antitumor Activity in Adult T-Cell Leukemia/Lymphoma

December 2nd 2020, 2:00pm

Study results also determined that immune system status before treatment may predict outcomes post-treatment.

Smiling Through Cancer Treatment Amid the COVID-19 Pandemic

November 26th 2020, 4:00pm

In this episode of the “CURE Talks Cancer” podcast, we spoke with a teenager who was diagnosed with Hodgkin lymphoma at the start of the COVID-19 pandemic. We talked about her cancer journey, what it was like to receive treatment during the pandemic, and more.

CAR T Therapy for Relapsed/Refractory DLBCL: Brian’s Story

November 25th 2020, 5:00am

From Chemotherapy to Constituents: Maryland Governor Faces Cancer, Politics

November 10th 2020, 4:00pm

Doctors told Maryland Governor Larry Hogan to go home and rest after undergoing cancer surgery. But he had other plans: sharing his health issues.

On Demand: Educated Patient® Leukemia and Lymphoma Summit

October 27th 2020, 7:00pm

View the entire CURE® Educated Patient® Leukemia & Lymphoma Summit. A virtual event seeking to educate, inform and challenge the thinking of patients with leukemia and lymphoma.

Friday Frontline: Jeff Bridges Receives a Lymphoma Diagnosis; Controversial Radio Host Rush Limbaugh Announces His Lung Cancer Has Progressed; And More

October 23rd 2020, 3:00pm

From acclaimed actor Jeff Bridges tweeting about a new lymphoma diagnosis to controversial conservative radio host Rush Limbaugh announcing that his stage 4 lung cancer has progressed, here’s what’s happening in the cancer landscape this week.

FDA Approves Keytruda for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma

October 15th 2020, 12:30pm

Data from the trial that led to the FDA approval demonstrated that Keytruda reduced the risk of progression or death in patients with relapsed or refractory classical Hodgkin lymphoma by 35%, compared to Adcetris.

What the FDA’s New Breast Implant Recommendations Mean for Patients

September 30th 2020, 6:00pm

In an interview with CURE®, the president of the National Center for Health Research elaborates on the effort to protect patients from potentially serious side effects associated with getting breast implants, including breast implant-associated anaplastic large cell lymphoma.

FDA Updates Breast Implant Labeling Recommendations to Help Inform Patients About Dangerous Potential Side Effects

September 29th 2020, 5:30pm

New guidance from the Food and Drug Administration recommends that the makers of breast implants include a black-box warning, a patient decision checklist and other information on product labels that will help protect them against a cancer and an autoimmune condition that can arise from use of the devices.

New Therapies for Adults and Children With Blood Cancers Hold Promise

September 25th 2020, 9:00pm

In this special hematology focused issue of CURE® we look at all the promising treatments and research for both adults and children with blood cancers.